Table 2.
Clinical outcomes
| Underweight (n = 660)  | 
Normal weight (n = 3936)  | 
Overweight (n = 1921)  | 
Obesity (n = 2613)  | 
P-value | |
|---|---|---|---|---|---|
| DGF | 21 (3.2%) | 170 (4.3%) | 63 (3.3%) | 120 (4.6%) | 0.079 | 
| Acute rejection | 132 (20.0%) | 706 (17.9%) | 333 (17.3%) | 530 (20.3%) | 0.031 | 
| de novo DSA | 61 (9.2%) | 375 (9.5%) | 217 (11.3%) | 239 (9.1%) | 0.082 | 
| Death-censored allograft loss | 18 (2.7%) | 101 (2.6%) | 55 (2.9%) | 96 (3.7%) | 0.073 | 
| Cardiovascular events | 48 (7.3%) | 228 (5.8%) | 128 (6.7%) | 163 (6.2%) | 0.371 | 
| All-cause mortality | 15 (2.3%) | 83 (2.1%) | 41 (2.1%) | 61 (2.3%) | 0.935 | 
Data are presented as number (%)
Abbreviations: DGF, delayed graft function; DSA, donor specific antigen